Benefit of everolimus in treatment of an intrahepatic cholangiocarcinoma patient with a PIK3CA mutation

Intrahepatic cholangiocarcinoma (ICC) is a relatively rare form of liver cancer with a poor prognosis. The therapeutic options for patients with advanced ICC are limited and usually ineffective. There is currently no approved targeted therapy for ICC, although accumulating evidence supports inhibiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Bian, Ji-Lai, Wang, Mei-Mei, Tong, En-Juan, Sun, Jing, Li, Ming, Miao, Zhi-Bo, Li, Yan-Lin, Zhu, Bai-Hong, Xu, Jia-Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483506/
https://www.ncbi.nlm.nih.gov/pubmed/28694672
http://dx.doi.org/10.3748/wjg.v23.i23.4311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483506/
https://www.ncbi.nlm.nih.gov/pubmed/28694672
http://dx.doi.org/10.3748/wjg.v23.i23.4311

Ejemplares similares